Paratek Pharmaceuticals (PRTK) Commences $50M Offering of Common Stock

January 17, 2018 4:07 PM UTC Send to a Friend
Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login